pembrolizumab
FDA approves Keytruda pembrolizumab as first line immunotherapy for advanced colorectal cancer
- December 24, 2020
- 0
- Category:
- Tags: cancerchemotherapyimmunotherapyKeytrudapembrolizumabTreatment Innovation
This is the 9th FDA drug approval supported by Stand Up To Cancer research.The FDA recently approved the immunotherapy drug pembrolizumab as a first-line treatment for patients with certain types...
Read